AZD0516
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Topoisomerase
Related Pathways
DNA Damage/DNA Repair, Antibody-drug Conjugate/ADC Related
Bioactivity
AZD0516 is a pioneering antibody-drug conjugate (ADC) targeting Six Transmembrane Epithelial Antigen of the Prostate 2 (STEAP2) . It is composed of an anti-STEAP2 monoclonal antibody (mAb) linked via a cysteine-maleimide reactive, β-glucuronidase-cleavable linker to the topoisomerase 1 inhibitor Exatecan. AZD0516 is applicable for prostate cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15292487 1 Vial
Lentiviral human C3orf18 shRNA (UAS) - Lentiviral human C3orf18 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 
GTR15119065 1 Vial
Lentiviral human PAGE2 shRNA (UAS) - Lentiviral human PAGE2 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details MBS1006137-01 0.05 mg (E-Coli)
Recombinant Cycas revoluta Peroxidase 7
Sign In for Pricing
View Details